Time to Hospital Evaluation in Patients of Acute Stroke for Alteplase Therapy
|
|
- Anabel Campbell
- 6 years ago
- Views:
Transcription
1 1 Original Article Time to Hospital Evaluation in Patients of Acute Stroke for Alteplase Therapy Asad Mahmood,* Muhammad Ashraf Sharif,** Umar Zafar Ali,* Muhammad Naeem Khan* From *Military Hospital (MH), Rawalpindi and **Armed Forces Institute of Pathology, Rawalpindi. Correspondence: Dr. Muhammad Ashraf Sharif, House No: 107, Street: 110 Sector G-11/3, Islamabad. Tel: Received: April 12, 2008 Accepted: October 25, 2008 ABSTRACT Objective: To determine the time from onset of symptoms to hospital evaluation in patients with acute cerebro-vascular accidents to assess their eligibility for thrombolytic therapy. Materials and Methods: This cross sectional observational study was carried out from March 2004 to September 2004 at the Department of Neurology, Military Hospital, Rawalpindi on 95 patients with acute cerebro-vascular accident. Patients of stroke presenting in outpatient and emergency department within 72 hours of onset of symptoms were included in the study. NIH Stroke Scale (NIHSS) was assessed at time of admission and all had CT scan. Time of onset of symptoms, arrival at ER/OPD to time taken by resident or neurologist in attending patient and time of getting CT scan were noted. Results: Of 95 patients, 20 (21%) were hemorrhagic and 75 (79%) were ischemic in nature. Median time of arrival to hospital from onset of symptoms was 12hrs (range 1-72hrs). Median time taken by resident to attend patient was 10min (range 2-30mins). CT brain was performed within 90min (range ) after arrival in hospital. Arrival within 1
2 2 3 hours of symptoms was seen in 16 (16.8%) patients, 13 (13.7%) patients within 6hrs while 66 (69.5%) patients after 6hrs. When adjusted for hospital delay and excluding the patients with hemorrhagic infarcts, 4 (4.2%) patients arrived within 3hrs and were most appropriate candidates for thrombolytic therapy. There were 11 (11.6%) patients assessed within 6hrs while the majority 80 (84.2%) came after 6hrs. Conclusion: Most patients with stroke do not reach hospital in time and are not suitable candidates for thrombolytic therapy. (Rawal Med J 2009;34:43-46). Key Words: Stroke, cerebrovascular accident, thrombolytic therapy. INTRODUCTION Stroke is the third main cause of death and the leading cause of long term disability. 1 In the United States alone approximately 750,000 strokes occur annually with mortality rate exceeding 150, In Pakistan, India, China, Nepal, Sri Lanka and Thailand there has been increase in stroke mortality due to increased risk factors and poor socioeconomic and health system. 3 A National Health Survey carried out at Aga Khan University, Pakistan, identified 33% prevalence of hypertension in adult population, with 2 million diabetics and 20% population of smokers or tobacco users. 4 Despite the approval of thrombolytic therapy for ischemic stroke in 1996 by FDA, the number of patients benefiting from it have been small. 5-6 Those benefited the most were who reported within a narrow therapeutic window limited to 3 hours only. 7 However, only 1% to 2% of patients with ischemic stroke are estimated to be treated within 3 hrs in various centers with maximum of 5% in selected centers. 5,8 Failure to reach the hospital in time is the main reason in majority of patients and therefore has been extensively 2
3 3 studied all over the world In Pakistan, due to low level of awareness and general education, rampant alternative therapies and lack of adequate health transport system, the time to seek treatment is especially prolonged. Earlier local studies have shown prehospital delay of 6-9 hours in the majority of the patients. 15,16 The objective of this study was to evaluate the time that patients take to reach hospital from the onset of symptoms and the emergency evaluation till the final diagnosis of stroke so as to assess the feasibility of thrombolytic therapy. MATERIALS AND METHODS This study was conducted at Military Hospital, Rawalpindi from 21 st March 2004 to 23 rd September Stroke was defined as rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hrs or leading to death, confirming to a vascular territory and without other evident cause. Patients with age >18 years and symptoms of less than 72 hours were included in the study. Those who had recurrent strokes were excluded from the study. Clinical diagnosis was established, NIHSS score was calculated and CT brain was performed in all patients. Time of onset was ascertained from patients or relatives. Symptom onset time was defined as the time when the patient first became aware of the symptoms. For patients who woke up with symptoms, time of onset was taken as time at which patient went to sleep and for those who were admitted unconscious; time of onset was taken as the last time they were witnessed to be well. Time of arrival to the hospital and time taken by a resident to attend the patient was endorsed on the predesigned proforma. Time of CT scan was noted from the record film. 3
4 4 Pre-hospital delay was defined as the time from onset of symptoms till arrival in the ER/OPD. In-hospital delay included time taken for visit by an internist and till the time CT scan is done. Total time delay included the pre-hospital and in-hospital time and was a measure of eligibility for thrombolytic therapy. Data was entered into SPSS v Median time interval for both pre hospital and in-hospital delay was calculated with minimum and maximum range. The pre-hospital time was divided into three groups as patients arriving within 3hrs, within 6hrs and after 6hrs. RESULTS A total of 95 patients fulfilled the inclusion criteria and 79% were males and 21% females. Mean age was 62 years (range 34-85). Ischemic stroke was more common (78.9%) as compared to hemorrhagic stroke (21.1%). Most of the patients were brought to hospital in a taxi (67.4%) as compared to ambulance (14.7%) or private car (17.9%). The median pre-hospital delay time was 12hrs with a range of 1 to 72hrs. Mean prehospital delay was 19hrs. Approximate 17% arrived to hospital within 3hrs, 14% arrived within 6hrs and rest of the subjects (69%) came after 6hrs (Figure 1). Fig 1. Pre hospital time delay in patients with stroke (n=95). 4
5 Within 3 hours Within 6 hours After 6 hours 0 Within 3 hours Within 6 hours After 6 hours The median time delay to attend by a resident was 10 min with a range of 2 min to 30 min. Mean time delay was 12 min. CT scan brain was performed with a median time delay of 90min with range from 10 to 390min. Mean time interval was 117min (approx 2hrs). When adjusted for in-hospital delay and excluding the patients with hemorrhagic stroke who arrived early, patients with a total delay time of less than 3hrs were only 4.2%, as compared to those who arrived in less than 6hrs (11.6%). Patients coming later than 6hrs were 84.2% (Figure 2). 5
6 6 Fig 2. Pre hospital time delay in patients with ischemic stroke (n=75) <3 hours < 6 hours > 6 hours This reflects that although 17% of patients arrived within 3 hrs yet only 4.2% were true candidates for thrombolytic therapy and out of the rest 12.8%, 4.2% had hemorrhagic stroke while 8.6% accounted for in-hospital delay. DISCUSSION Studies of cerebral blood flow measurement based upon Kety-Schmidt principle have revealed that after occlusion of an artery there is region of brain that is threatened but viable and it was termed the ischemic penumbra and the time this zone would remain viable was called therapeutic time window. Though degree of occlusion, presence of collaterals and extent of spontaneous reperfusion can vary, animal studies have 6
7 7 consistently shown that reperfusion within 3 hours of arterial occlusion will limit the size of infarct and improve the outcome. 17 This scientific dictum has given origin to the concept of time delay which has been defined as time it takes from stroke onset to initiation of acute medical intervention. As the first step, we have tried to establish delay time in our community. Around 17% of patients arrived within 3 hours and further 14% arrived within 6 hours of onset of symptoms, a result which is far from ideal. The mean pre-hospital delay in the present study was 5.4 hours with a total of 56% patients arriving within 3 hours. This time lapse is similar to earlier studies by Basharat et al 15 and Siddiqui et al 16 in Pakistan. The mean time delay for CT scan in Genentech Stroke Presentation Survey was 1.9 hours. 18 A similar result was reported by a UK based study which identified that 37% patients reported within 3 hours and 50% in 6hours. 19 Stroke unit admission were shown to be 29% in 3 hours and 75% within 6 hours in a French stroke unit basically due to Emergency Medical Services and Fire Department ambulances. 12 In Beijing China, median time from onset to ED was 5.17 hours and time for CT was 10 minutes with 78.2% of patients treated within one hour. 13 At a center in New Delhi India 25% of patients were admitted within 3hours of symptom onset, a result comparable to our population but they had significant higher percentage at 6 hours (49%). 14 Although the present study did not address the factors causing the time delay, lack of awareness, low threat perception, non-availablility of ambulance services and contact with local general practitioner have been attributed for this delay in previous studies. 15,16 In conclusion, only 17% stroke patient arrived at hospital within three hours of onset of symptoms. Efforts should be made to reduce the delays at all levels. With poor socio- 7
8 8 economic structure, low level of education and awareness, lack of health services and rising incidence of risk factors for stroke, the need seems to be all the more important. REFERENCES 1. Bonita R. Epidemiology of stroke. Lancet. 1992;339: Thom T, Haase N, Rosamond W, Howard VJ, John Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation.2006;113: Singh RB, Suh IL, Singh VP, Chaithiraphan S, Laothavorn P, Sy RG, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens.2000;14: Pakistan Medical Research Council, National Health Survey of Pakistan. Health profile of the people of Pakistan. 1998, pp Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke.1998;29: NINDS t-pa Stroke Study Group. Generalized efficacy of t-pa for acute stroke: subgroup analysis of the NINDS t-pa Stroke Trial. Stroke.1997;28: Marler JR, Tilley BC, Lu M, Broderick J, Brott T, Lyden P, et al. Early stroke treatment associated with better outcome: the NINDS rt-pa stroke study. Neurology.2000;55:
9 9 8. Engelstein E, Margulies J, Jeret JS. Lack of t-pa use for acute ischemic stroke in a community hospital: high incidence of exclusion criteria. Am J Emerg Med.2000: 18: Smith MA, Doliszny KM, Shahar E, Mcgovern PG, Arnett DK, Luepker RV. Delayed hospital arrival for acute stroke: the Minnesota Stroke Survey. Ann Intern Med.1998;129: Morris D, Rosamond W, Hinn A, Gorton R. Time delays in accessing stroke care in the emergency department. Acad Emerg Med.1999;6: Lacy CR, Suh DC, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke: stroke time registry for outcomes knowledge and epidemiology (S.T.R.O.K.E.). Stroke.2001;32: Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P. Factors influencing early stroke admission in French stroke unit. Stroke. 2002;33: Wang S, Niu S, Wang Y, Zhang G. Evaluation of the factors leading to delay from stroke onset to arrival at hospital. Zhonghua Nei Ke Za Zhi.2002;41: Srivastava AK, Prasad K. A study of factors delaying hospital arrival of patients with acute stroke. Neurol India.2001;49: Basharat RA, Mirza KR, Qamar MY. Delay in presentation of acute ischemic stroke in Lahore General Hospital, Lahore. Ann King Edward Med Coll. 2005;11: Siddiqui M, Siddiqui SR, Zafar A, Khan FS. Factors delaying hospital arrival of patients with acute stroke. J Pak Med Assoc.2008;58:
10 Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981;54: Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke. The Genentech Stroke Presentation Survey. Stroke 2000;31: Harraf F, Sharma AK, Brown MM, Lees KR, Vass RI, Kalra L. A multicentre observational study of presentation and early assessment of acute stroke. Brit Med J 2002;325:17. 10
11 11 11
A retrospective study on intracerebral haemorrhage reduction by MRI versus CT in intravenous thrombolysis for acute ischaemic stroke
Hong Kong Journal of Emergency Medicine A retrospective study on intracerebral haemorrhage reduction by MRI versus CT in intravenous thrombolysis for acute ischaemic stroke YH Yun, JY Chung, MJ Kang, JT
More informationFactors Influencing Pre-Hospital Delay after Ischemic Stroke and Transient Ischemic Attack
ORIGINAL ARTICLE Factors Influencing Pre-Hospital Delay after Ischemic Stroke and Transient Ischemic Attack Yuko Tanaka 1, Makoto Nakajima 1, Teruyuki Hirano 2 and Makoto Uchino 2 Abstract Background and
More informationThrombolytic therapy can improve neurological outcomes
Prehospital Notification by Emergency Medical Services Reduces Delays in Stroke Evaluation Findings From the North Carolina Stroke Care Collaborative Mehul D. Patel, MSPH; Kathryn M. Rose, PhD; Emily C.
More informationThe administration of intravenous tissue plasminogen
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke A Canadian Hospital s Experience Kristine M. Chapman, MD; Andrew R. Woolfenden, MD; Douglas Graeb, MD; Dean C.C. Johnston, MD; Jeff Beckman,
More informationSupplementary Online Content
Supplementary Online Content Wolters FJ, Li L, Gutnikov SA, Mehta Z, Rothwell PM. Medical attention seeking after transient ischemic attack and minor stroke in relation to the UK Face, Arm, Speech, Time
More informationPresentation Time to Hospital and Recognition of Stroke in Patients with Ischemic Stroke
Presentation Time to Hospital and Recognition of Stroke in Patients with Ischemic Stroke Ji Hoe Heo, M.D., Hwa Young Cheon, M.D., Chung Mo Nam, Ph.D.*, Dong Chan Kim, R.N., Gyung Whan Kim, M.D., Byung
More informationMechanical thrombectomy in Plymouth. Will Adams. Will Adams
Mechanical thrombectomy in Plymouth Will Adams Will Adams History Intra-arterial intervention 1995 (NINDS) iv tpa improved clinical outcome in patients treated within 3 hours of ictus but limited recanalisation
More informationCanadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationSTROKE is a major cause of disability and
218 STROKE DELAYS Morris et al. STROKE CARE DELAYS EDUCATION AND PRACTICE Time Delays in Accessing Stroke Care in the Emergency Department DEXTER L. MORRIS, PHD, MD, WAYNE D. ROSAMOND, PHD, ALBERT R. HINN,
More informationMaking every second count Challenges in acute stroke management Prehospital management of acute ischaemic stroke: how can we do better?
Making every second count Challenges in acute stroke management Prehospital management of acute ischaemic stroke: how can we do better? Patrick Goldstein, MD, Lille, France NIH-recommended emergency department
More informationRural emergency department best practice for treatment of acute ischemic stroke
Rural emergency department best practice for treatment of acute ischemic stroke Aubrey J. Hoye, DO Ministry Howard Young Medical Center, Woodruff, WI Ministry Eagle River Memorial Hospital, Eagle River,
More informationThrombolytic Therapy in Clinical Practice The Norwegian Experience
Thrombolytic Therapy in Clinical Practice The Norwegian Experience Thomassen Lars Thomassen, Ulrike Waje-Andreassen, Halvor Næss ABSTRACT Background: Awaiting the European approval of thrombolysis, we
More informationFactors Delaying Hospital Arrival after Acute Stroke in Southern Taiwan. Teng-Yeow Tan, MD; Ku-Chou Chang, MD; Chia-Wei Liou, MD
Original Article 458 Factors Delaying Hospital Arrival after Acute Stroke in Southern Taiwan Teng-Yeow Tan, MD; Ku-Chou Chang, MD; Chia-Wei Liou, MD Background: Acute stroke management emphasizes prompt
More informationThrombolysis with recombinant tissue plasminogen activator
Delay in Presentation After an Acute Stroke in a Multiethnic Population in South London: The South London Stroke Register Juliet Addo, PhD; Salma Ayis, PhD; Josette Leon, BSc; Anthony G. Rudd, FRCP; Christopher
More informationACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke
ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center
More informationClinical Study Experiences of Thrombolytic Therapy for Ischemic Stroke in Tuzla Canton, Bosnia and Herzegovina
ISRN Stroke, Article ID 313976, 4 pages http://dx.doi.org/10.1155/2014/313976 Clinical Study Experiences of Thrombolytic Therapy for Ischemic Stroke in Tuzla Canton, Bosnia and Herzegovina DDevdet SmajloviT,DenisaSalihoviT,
More informationUPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015
UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015 NEW STUDIES FOR 2015 MR CLEAN ESCAPE EXTEND-IA REVASCAT SWIFT PRIME RECOGNIZED LIMITATIONS IV Alteplase proven benefit
More informationSafety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
Original Article Medical Journal of the Islamic Republic of Iran, Vol. 27, No. 3, Aug 2013, pp. 113-118 Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic
More informationEmergency Department Stroke Registry Process of Care Indicator Specifications (July 1, 2011 June 30, 2012 Dates of Service)
Specifications Description Methodology NIH Stroke Scale (NIHSS) Performed in Initial Evaluation used to assess the percentage of adult stroke patients who had the NIHSS performed during their initial evaluation
More informationCOMPREHENSIVE SUMMARY OF INSTOR REPORTS
COMPREHENSIVE SUMMARY OF INSTOR REPORTS Please note that the following chart provides a sampling of INSTOR reports to differentiate this registry s capabilities as a process improvement system. This list
More informationFrequency of Cardiac Risk Factors in. Ischemic
Frequency of Cardiac Risk Factors in Ischemic Stroke CORRESPONDING AUTHOR: MUSHTAQUE AHMED, MD EMAIL: BUGHIOAHMED@GMAIL.COM NEW YORK PRESBYTERIAN WEILL CORNELLL MEDICAL COLLEGE, NY ABSTRACT Stroke is the
More informationAwareness of stroke among stroke patients in a tertiary-care level hospital in northwest India
Research Article Awareness of stroke among stroke patients in a tertiary-care level hospital in northwest India Sulena Sulena, Banshi Lal Kumawat, Anjani Kumar Sharma Department of Neurology, SMS Medical
More informationUnclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018
Unclogging The Pipes Zahraa Rabeeah MD Chief Resident February 9,2018 Please join Polleverywhere by texting: ZRABEEAH894 to 37607 Disclosures None Objectives Delineate the differences between TPA vs thrombectomy
More informationGUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
More informationStroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center
Stroke Update 2015 Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center Objectives 1. Review successes in systems of care approach to acute ischemic stroke
More informationArticle ID: WMC ISSN
Article ID: WMC004795 ISSN 2046-1690 Correlation of Alberta Stroke Program Early Computed Tomography Score on CT and Volume on Diffusion Weighted MRI with National Institutes of Health Stroke Scale Peer
More informationDisclosures. Anesthesia for Endovascular Treatment of Acute Ischemic Stroke. Acute Ischemic Stroke. Acute Stroke = Medical Emergency!
Disclosures Anesthesia for Endovascular Treatment of Acute Ischemic Stroke I have nothing to disclose. Chanhung Lee MD, PhD Associate Professor Anesthesia and perioperative Care Acute Ischemic Stroke 780,000
More informationStroke: Effect of Implementing an Evaluation and Treatment Protocol Compliant with NINDS Recommendations 1
James E. Stahl, MD, CM, MPH Karen L. Furie, MD Suzanne Gleason, PhD G. Scott Gazelle, MD, MPH, PhD Index terms: Brain, infarction, 13.78 Cost-effectiveness Economics, medical Radiology and radiologists,
More informationRole of recombinant tissue plasminogen activator in the updated stroke approach
Role of recombinant tissue plasminogen activator in the updated stroke approach Joshua Z. Willey, MD, MS Assistant Professor of Neurology Division of Stroke, Columbia University October 2015 jzw2@columbia.edu
More informationPerils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion
Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion Aman B. Patel, MD Robert & Jean Ojemann Associate Professor Director, Cerebrovascular Surgery Director, Neuroendovascular
More informationStroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke
Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke Alexander A. Khalessi MD MS Director of Endovascular Neurosurgery Surgical Director of NeuroCritical Care University
More informationParameter Optimized Treatment for Acute Ischemic Stroke
Heart & Stroke Barnett Memorial Lectureship and Visiting Professorship Parameter Optimized Treatment for Acute Ischemic Stroke December 2, 2016, Thunder Bay, Ontario Adnan I. Qureshi MD Professor of Neurology,
More informationNHL Journal of Medical Sciences/July 2014/Vol 3/Issue 2 18
Research article NIHSS Score: A handy tool to predict vascular occlusion in acute ischemic stroke Ronak Shah*, Chintal Vyas**, Jyoti Vora*** *Senior Resident, **Assistant Professor, ***Associate Professor,
More informationLatest Advances in the Neurointerventional Treatment of Ischemic Stroke P A C I F I C N E U R O. O R G
Latest Advances in the Neurointerventional Treatment of Ischemic Stroke Neurointerventional Management of Ischemic Stroke 1. Thrombectomy for acute ischemic stroke 2. Carotid artery stenting 3. Management
More informationClinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke
Research Article imedpub Journals http://www.imedpub.com Clinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke Abstract Background: The number of patients who are adopted
More informationAcute ischemic stroke is a major cause of morbidity
Outcomes of Treatment with Recombinant Tissue Plasminogen Activator in Patients Age 80 Years and Older Presenting with Acute Ischemic Stroke Jennifer C. Drost, DO, MPH, and Susana M. Bowling, MD ABSTRACT
More informationStroke remains the third leading cause of death and the
Stroke Symptoms and the Decision to Call for an Ambulance Ian Mosley, MBus; Marcus Nicol, PhD; Geoffrey Donnan, MD; Ian Patrick, ASM; Helen Dewey, PhD Background and Purpose Few acute stroke patients are
More information7 TI - Epidemiology of intracerebral hemorrhage.
1 TI - Multiple postoperative intracerebral haematomas remote from the site of craniotomy. AU - Rapana A, et al. SO - Br J Neurosurg. 1998 Aug;1():-8. Review. IDS - PMID: 1000 UI: 991958 TI - Cerebral
More informationJournal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study
Journal Club Articles for Discussion Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995 Dec
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationStroke Systems of Care Claire Corbett, MMS, NRP Manager of Neurodiagnostics and Stroke Center New Hanover Regional Medical Center. What do we know?
Stroke Systems of Care Claire Corbett, MMS, NRP Manager of Neurodiagnostics and Stroke Center New Hanover Regional Medical Center What do we know? Stroke: Time is Brain Shorter onset to treatment times
More informationEndovascular Treatment Updates in Stroke Care
Endovascular Treatment Updates in Stroke Care Autumn Graham, MD April 6-10, 2017 Phoenix, AZ Endovascular Treatment Updates in Stroke Care Autumn Graham, MD Associate Professor of Clinical Emergency Medicine
More information10/26/2016. Disclosures. Mobile Stroke Units
Mobile Stroke Units Andrei V. Alexandrov, MD Semmes-Murphey Professor and Chairman Department of Neurology Medical Director, Mobile Stroke Unit, UT Clinical Health Memphis, TN Disclosures Funding: Assisi
More information: STROKE. other pertinent information such as recent trauma, illicit drug use, pertinent medical history or use of oral contraceptives.
INTRODUCTION A cerebral vascular accident (CVA) or stroke is a lack of blood supply to the brain as a result of either ischemia or hemorrhage. 80% of CVAs are a result of ischemia (embolic or thrombotic)
More informationA STUDY TO DETERMINE THE FACTORS ASSOCIATED WITH HOSPITAL ARRIVAL TIME FOR STROKE PATIENTS IN SCTIMST
A STUDY TO DETERMINE THE FACTORS ASSOCIATED WITH HOSPITAL ARRIVAL TIME FOR STROKE PATIENTS IN SCTIMST PROJECT REPORT Submitted in partial fulfillment of the requirements For the Diploma in Neuro Nursing
More informationMaximising Delivery of Thrombectomy
Maximising Delivery of Thrombectomy Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals Visiting Professor of Clinical
More informationCode Stroke in real life. Disclosures. Parkland Memorial Hospital. I have no disclosures. Has 1 million patient visits annually. Level 1 Trauma Center
Code Stroke in real life Alejandro Magadán, M.D. University of Texas Southwestern Medical Center Medical Director for Stroke Parkland Memorial Hospital Disclosures I have no disclosures Parkland Memorial
More information11/27/2017. Stroke Management in the Neurocritical Care Unit. Conflict of interest. Karel Fuentes MD Medical Director of Neurocritical Care
Stroke Management in the Neurocritical Care Unit Karel Fuentes MD Medical Director of Neurocritical Care Conflict of interest None Introduction Reperfusion therapy remains the mainstay in the treatment
More informationFirst Year of 24/7 ASU and Stroke Thrombolytic Service
First Year of 24/7 ASU and Stroke Thrombolytic Service Kwan M, Chang C, Mak W, Ip F, Chang R, Pang S, Hon S, Ho SL, Cheung RTF Division of Neurology, Department of Medicine, Queen Mary Hospital. IV Thrombolysis
More informationND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014
ND STROKE Coordinators Case Studies STEMI and Stroke Conference, Fargo, ND, August 5, 2014 STROKE Coordinator Case Study Essentia Health, Fargo Essentia Health Stroke Alert Process Within 24 hours of Last
More informationAntithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding
Get With The Guidelines -Stroke is the American Heart Association s collaborative performance improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized with
More informationHow Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage
How Low Should You Go? Management of Blood Pressure in Intracranial Hemorrhage Rachael Scott, Pharm.D. PGY2 Critical Care Pharmacy Resident Pharmacy Grand Rounds August 21, 2018 2018 MFMER slide-1 Patient
More informationBY: Ramon Medina EMT-LP/RN
BY: Ramon Medina EMT-LP/RN Discuss types of strokes Discuss the physical and neurological assessment of stroke patients Discuss pertinent historical findings Discuss pre-hospital and emergency management
More informationAcute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center
Acute Stroke Care: the Nuts and Bolts of it Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center ECASS I and II tpa for patients presenting
More informationHERMES Time and Workflow Primary Paper. Statistical Analysis Plan
HERMES Time and Workflow Primary Paper Statistical Analysis Plan I. Study Aims This is a post-hoc analysis of the pooled HERMES dataset, with the following specific aims: A) To characterize the time period
More informationBlood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang, Chung-Shiuan Chen, Qi Zhao, Jing Chen for CATIS
More informationORIGINAL CONTRIBUTION. Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke
Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke Houston Experience 1996 to 2000 ORIGINAL CONTRIBUTION James C. Grotta, MD; W. Scott Burgin, MD; Ashraf El-Mitwalli, MD; Megan Long;
More informationStroke Update. Claire J. Creutzfeldt, MD January 12, 2018
Stroke Update Claire J. Creutzfeldt, MD January 12, 2018 Disclosures None relevant to this presentation I receive funding from the NINDS What s new in stroke? A new model for cardioembolic stroke: atrial
More informationBuilding a Stroke Portfolio. June 28, 2018
Building a Stroke Portfolio June 28, 2018 1 Forward-Looking Statements This presentation contains forward-looking statements, including statements relating to: the potential benefits, safety and efficacy
More informationPrevalence and Characteristics of Stroke in Internally Displaced Peoples Admitted to a Hospital in Bannu
Original Article Prevalence and Characteristics of Stroke in Internally Displaced Peoples Admitted to a Hospital in Bannu Abdul Razzaq 1, Tehsinullah 2, Wasim Ahmed 3, Mohammad Nadeem Khan 4, Mohammad
More informationAdvances in Neuro-Endovascular Care for Acute Stroke
Advances in Neuro-Endovascular Care for Acute Stroke Ciarán J. Powers, MD, PhD, FAANS Associate Professor Program Director Department of Neurological Surgery Surgical Director Comprehensive Stroke Center
More informationProtocol for IV rtpa Treatment of Acute Ischemic Stroke
Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and
More informationBroadening the Stroke Window in Light of the DAWN Trial
Broadening the Stroke Window in Light of the DAWN Trial South Jersey Neurovascular and Stroke Symposium April 26, 2018 Rohan Chitale, MD Assistant Professor of Neurological Surgery Vanderbilt University
More informationStroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012
Stroke & the Emergency Department Dr. Barry Moynihan, March 2 nd, 2012 Outline Primer Stroke anatomy & clinical syndromes Diagnosing stroke Anterior / Posterior Thrombolysis Haemorrhage The London model
More informationUpdated tpa Guidelines: Expanding the opportunity for good outcomes. Benjamin Morrow, MSN RN UPMC Stroke Institute
Updated tpa Guidelines: Expanding the opportunity for good outcomes Benjamin Morrow, MSN RN UPMC Stroke Institute 1 Outline History Current State Review Exclusions: Minor stroke symptoms Severe strokes
More informationTENNESSEE STROKE REGISTRY QUARTERLY REPORT
TENNESSEE STROKE REGISTRY QUARTERLY REPORT Volume 1, Issue 3 September 2018 This report is published quarterly using data from the Tennessee Stroke Registry. Inside this report Data on diagnosis, gender
More informationStroke Treatment Beyond Traditional Time Windows. Rishi Gupta, MD, MBA
Stroke Treatment Beyond Traditional Time Windows Rishi Gupta, MD, MBA Director, Stroke and Neurocritical Care Endovascular Neurosurgery Wellstar Health System THE PAST THE PRESENT 2015 American Heart Association/American
More informationTENNESSEE STROKE REGISTRY QUARTERLY REPORT
TENNESSEE STROKE REGISTRY QUARTERLY REPORT Volume 1, Issue 2 July 2018 This report is published quarterly using data from the Tennessee Stroke Registry. Inside this report Data on diagnosis, gender distributions,
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationUpdates in Stroke Management. Jessica A Starr, PharmD, FCCP, BCPS Associate Clinical Professor Auburn University Harrison School of Pharmacy
Updates in Stroke Management Jessica A Starr, PharmD, FCCP, BCPS Associate Clinical Professor Auburn University Harrison School of Pharmacy Disclosure I have no actual or potential conflict of interest
More informationStroke Thrombolysis. Dr Peter Anderton (Stroke Consultant DBTH)
Stroke Thrombolysis Dr Peter Anderton (Stroke Consultant DBTH) Thrombolysis for ischaemic stroke Rationale Restoration of blood flow Salvage of ischaemic penumbra Schematic of the mismatch model for defining
More informationComparison of outcome of etiological factors for non-traumatic coma in geriatric population in India
Original article: Comparison of outcome of etiological factors for non-traumatic coma in geriatric population in India 1 DrAmit Suresh Bhate, 2 DrSatishNirhale, 3 DrPrajwalRao, 4 DrShubangi A Kanitkar
More informationQuality ID #187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy National Quality Strategy Domain: Effective Clinical Care
Quality ID #187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process
More informationPrevalence of cerebrovascular accidents (CVA) in obese hypertensives among inpatients of Govt.General Hospital, Guntur
Original article Prevalence of cerebrovascular accidents (CVA) in obese hypertensives among inpatients of Govt.General Hospital, Guntur 1 Dr. Dr.Uday Shankar Sanakayala, 2 Dr. T. V. Adi Seshu Babu, 3 Dr.
More informationJMSCR Vol 3 Issue 12 Page December 2015
www.jmscr.igmpublication.org Impact Factor 3.79 Index Copernicus Value: 5.88 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v3i12.07 Study of Lipid Profile in Ischemic Cerebrovascular
More informationSymptomatic intracerebral hemorrhage (sich) after
Reduced Pretreatment Ipsilateral Middle Cerebral Artery Cerebral Blood Flow Is Predictive of Symptomatic Hemorrhage Post Intra-Arterial Thrombolysis in Patients With Middle Cerebral Artery Occlusion Rishi
More informationframework for flow Objectives Acute Stroke Treatment Collaterals in Acute Ischemic Stroke framework & basis for flow
Acute Stroke Treatment Collaterals in Acute Ischemic Stroke Objectives role of collaterals in acute ischemic stroke collateral therapeutic strategies David S Liebeskind, MD Professor of Neurology & Director
More informationThe International Journal of Neuroscience
The Underlying Factor Structure of National Institutes of Health Stroke Scale: An Exploratory Factor Analysis Journal: The International Journal of Neuroscience Manuscript ID: GNES-0-0 Manuscript Type:
More informationMohamed Al-Khaled, MD,* Christine Matthis, MD, and J urgen Eggers, MD*
Predictors of In-hospital Mortality and the Risk of Symptomatic Intracerebral Hemorrhage after Thrombolytic Therapy with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Mohamed Al-Khaled,
More informationIntravenous thrombolysis in acute ischemic stroke our experience
Romanian Neurosurgery (2017) XXXI 2: 137-145 137 DOI: 10.1515/romneu-2017-0021 Intravenous thrombolysis in acute ischemic stroke our experience Tudor Cuciureanu 1, Diana Hodorog 2,3, Iulian Dan Cuciureanu
More informationAcute Stroke Treatment: Current Trends 2010
Acute Stroke Treatment: Current Trends 2010 Helmi L. Lutsep, MD Oregon Stroke Center Oregon Health & Science University Overview Ischemic Stroke Neuroprotectant trials to watch for IV tpa longer treatment
More informationStroke Net Grand Round Webinar
Stroke Net Grand Round Webinar Preconditioning the Brain for Stroke Prevention April 4, 2019 Sebastian Koch University of Miami Department of Neurology None Unique challenges in brain conditioning Review
More informationACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine
ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS Justin Nolte, MD Assistant Profession Marshall University School of Medicine History of Presenting Illness 64 yo wf with PMHx of COPD, HTN, HLP who was in
More informationAcute stroke management has changed over the past 10
Emergency Calls in Acute Stroke René Handschu, MD; Reinhard Poppe; Joachim Rauß; Bernhard Neundörfer, MD, PhD; Frank Erbguth, MD, PhD Background and Purpose In the last 10 years, stroke has become a medical
More informationAcute Ischaemic Stroke Pathways Drip and Ship
Acute Ischaemic Stroke Pathways Drip and Ship Professor Gary Ford Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals Visiting Professor
More informationEvidence for Mechanical ThrombectomyFor Acute Ischemic Stroke. Kenneth V Snyder MD PhD SUNY Buffalo, NY
Evidence for Mechanical ThrombectomyFor Acute Ischemic Stroke Kenneth V Snyder MD PhD SUNY Buffalo, NY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Honorarium
More informationFREQUENCY OF COMMON MODIFIABLE RISK FACTORS FOR STROKE
ORIGINAL ARTICLE FREQUENCY OF COMMON MODIFIABLE RISK FACTORS FOR STROKE Ashok Kumar Lahano, Mujahid Ali Chandio, Muhammad Irfan Bhatti Department of Medicine, Peoples University Hospital, Shaheed Benazirabad
More informationMAGNETIC RESONANCE IMAGING CRITERIA FOR THROMBOLYSIS IN HYPERACUTE CEREBRAL INFARCTION IN KOSOVA
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL MAGNETIC RESONANCE IMAGING CRITERIA FOR THROMBOLYSIS IN HYPERACUTE CEREBRAL INFARCTION IN KOSOVA PhD THESIS ABSTRACT PhD SUPERVISOR, PROFESSOR
More informationPatient characteristics. Intervention Comparison Length of followup. Outcome measures. Number of patients. Evidence level.
5.0 Rapid recognition of symptoms and diagnosis 5.1. Pre-hospital health professional checklists for the prompt recognition of symptoms of TIA and stroke Evidence Tables ASM1: What is the accuracy of a
More informationMRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe Dong-Wha Kang, MD, PhD; Julio A. Chalela, MD; William Dunn, MD; Steven Warach, MD, PhD; NIH-Suburban Stroke Center
More informationACUTE STROKE IMAGING
ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University
More informationHyperuricemia as a Prognostic Marker in Acute Ischemic Stroke
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/23 Hyperuricemia as a Prognostic Marker in Acute Ischemic Stroke B Balaji 1, Bingi Srinivas 2 1 Associate Professor,
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More informationPATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
Pak Heart J ORIGINAL ARTICLE PATTERN OF ANGIOGRAPHIC FINDINGS IN YOUNG PATIENTS PRESENTING WITH ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Burhan Akhtar, Nauman Ali, Rana Kashif - Department Of Cardiology,
More informationAndrew Barreto, MD MS Associate Professor of Neurology Stroke Neurologist UTHealth. May 23, 2018
Andrew Barreto, MD MS Associate Professor of Neurology Stroke Neurologist UTHealth May 23, 2018 Disclosure No personal financial relationships with any company. Presentation Outline Definitions, signs
More informationImaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital
Imaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital Disclosures Penumbra, Inc. research grant (significant) for
More informationRecent Changes in IV TPA Recommendations. Ashish Masih, M.D Vascular Neurology
Recent Changes in IV TPA Recommendations Ashish Masih, M.D Vascular Neurology Disclosures none 4 th leading cause of death Nearly 800,000 cases of stroke annually Statistics Leading cause of disability
More information